---
$id: https://graph.org.ai/products/commodity/51152041
$type: Product
source: UNSPSC
code: "51152041"
title: "Orphenadrine"
class: "51152000"
classTitle: "Neuromuscular blocking agents"
family: "51150000"
familyTitle: "Autonomic nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Orphenadrine

**UNSPSC Code**: 51152041
**Class**: [Neuromuscular blocking agents](Neuromuscular blocking agents.mdx)
**Family**: [Autonomic nervous system drugs](../Autonomic nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a muscle relaxant and antimuscarinic agent with the molecular formula C18H23NO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier AL805O9OG9, chemically known as n,n-dimethyl-2-(o-methyl-.alpha.-phenylbenzyloxy)ethylamine hydrochloride but generally known as orphenadrine, which bears US NIH Compound Identifier 4601. European Medicines Agency schedules Orphenadrine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09471MIG. ORPHENADRINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule orphenadrine under HS 29221980 and SITC 51461. As of Q4 2014, ORPHENADRINE remains the US FDA Preferred Term for this commodity. Orphenadrine bears US NLM identifiers UMLS ID C0029309 and NCI Concept Code C61868. SMILES: O(C(C1C(CCCC1)C)C1CCCCC1)CCN(C)C.

